Publication | Closed Access

S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial

HepatologyMedicineClinical TrialsPathologyLiver CancerS-1 Versus PlaceboCancer TreatmentOncologyRadiation OncologyHepatocellular CarcinomaPhase 3Health Sciences